# Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.

> **NCT04038710** · — · COMPLETED · sponsor: **National Jewish Health** · enrollment: 8 (actual)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** Triple combination therapy

## Key facts

- **NCT ID:** NCT04038710
- **Lead sponsor:** National Jewish Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-05
- **Primary completion:** 2021-02-26
- **Final completion:** 2021-02-26
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04038710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04038710, "Clinical Outcomes of Triple Combination Therapy in Severe Cystic Fibrosis Disease.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04038710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*